N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS

The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4- morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use. La presente invención se refiere a formas novedosas estables de...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: CARRA Ernest A, WARR Matthew Robert, MORRISON Henry, WHITNEY James Andrew, STEFANIDIS Dimitrios, XIN Yan, WANG Fang, BROWN Brandon H, HEMENWAY Jeffrey N, SHI Bing, REYNOLDS Troy
Format: Patent
Sprache:eng ; spa
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator CARRA Ernest A
WARR Matthew Robert
MORRISON Henry
WHITNEY James Andrew
STEFANIDIS Dimitrios
XIN Yan
WANG Fang
BROWN Brandon H
HEMENWAY Jeffrey N
SHI Bing
REYNOLDS Troy
description The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4- morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use. La presente invención se refiere a formas novedosas estables de sales de N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il )benzamida que son adecuadas para la preparación de las formulaciones farmacéuticas de las mismas y sus usos terapéuticos.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_MX2022015558A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>MX2022015558A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_MX2022015558A3</originalsourceid><addsrcrecordid>eNrjZIj209VwjnT08_d1DfGI9NHUNdHVMNLVMNH19Q8K8PD38fTzD_Bw9Yv0cfQFMjUDIoM8fT1dPP2A6oCqnVz9FKKAMi6uCh6RLkH-zh4-_kEgXrCjT0gwDwNrWmJOcSovlOZmUHJzDXH20E0tyI9PLS5ITE7NSy2J940wMjAyMjA0NTW1cDQmShEAsYQySg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS</title><source>esp@cenet</source><creator>CARRA Ernest A ; WARR Matthew Robert ; MORRISON Henry ; WHITNEY James Andrew ; STEFANIDIS Dimitrios ; XIN Yan ; WANG Fang ; BROWN Brandon H ; HEMENWAY Jeffrey N ; SHI Bing ; REYNOLDS Troy</creator><creatorcontrib>CARRA Ernest A ; WARR Matthew Robert ; MORRISON Henry ; WHITNEY James Andrew ; STEFANIDIS Dimitrios ; XIN Yan ; WANG Fang ; BROWN Brandon H ; HEMENWAY Jeffrey N ; SHI Bing ; REYNOLDS Troy</creatorcontrib><description>The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4- morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use. La presente invención se refiere a formas novedosas estables de sales de N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il )benzamida que son adecuadas para la preparación de las formulaciones farmacéuticas de las mismas y sus usos terapéuticos.</description><language>eng ; spa</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230130&amp;DB=EPODOC&amp;CC=MX&amp;NR=2022015558A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20230130&amp;DB=EPODOC&amp;CC=MX&amp;NR=2022015558A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>CARRA Ernest A</creatorcontrib><creatorcontrib>WARR Matthew Robert</creatorcontrib><creatorcontrib>MORRISON Henry</creatorcontrib><creatorcontrib>WHITNEY James Andrew</creatorcontrib><creatorcontrib>STEFANIDIS Dimitrios</creatorcontrib><creatorcontrib>XIN Yan</creatorcontrib><creatorcontrib>WANG Fang</creatorcontrib><creatorcontrib>BROWN Brandon H</creatorcontrib><creatorcontrib>HEMENWAY Jeffrey N</creatorcontrib><creatorcontrib>SHI Bing</creatorcontrib><creatorcontrib>REYNOLDS Troy</creatorcontrib><title>N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS</title><description>The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4- morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use. La presente invención se refiere a formas novedosas estables de sales de N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il )benzamida que son adecuadas para la preparación de las formulaciones farmacéuticas de las mismas y sus usos terapéuticos.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZIj209VwjnT08_d1DfGI9NHUNdHVMNLVMNH19Q8K8PD38fTzD_Bw9Yv0cfQFMjUDIoM8fT1dPP2A6oCqnVz9FKKAMi6uCh6RLkH-zh4-_kEgXrCjT0gwDwNrWmJOcSovlOZmUHJzDXH20E0tyI9PLS5ITE7NSy2J940wMjAyMjA0NTW1cDQmShEAsYQySg</recordid><startdate>20230130</startdate><enddate>20230130</enddate><creator>CARRA Ernest A</creator><creator>WARR Matthew Robert</creator><creator>MORRISON Henry</creator><creator>WHITNEY James Andrew</creator><creator>STEFANIDIS Dimitrios</creator><creator>XIN Yan</creator><creator>WANG Fang</creator><creator>BROWN Brandon H</creator><creator>HEMENWAY Jeffrey N</creator><creator>SHI Bing</creator><creator>REYNOLDS Troy</creator><scope>EVB</scope></search><sort><creationdate>20230130</creationdate><title>N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS</title><author>CARRA Ernest A ; WARR Matthew Robert ; MORRISON Henry ; WHITNEY James Andrew ; STEFANIDIS Dimitrios ; XIN Yan ; WANG Fang ; BROWN Brandon H ; HEMENWAY Jeffrey N ; SHI Bing ; REYNOLDS Troy</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_MX2022015558A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; spa</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>CARRA Ernest A</creatorcontrib><creatorcontrib>WARR Matthew Robert</creatorcontrib><creatorcontrib>MORRISON Henry</creatorcontrib><creatorcontrib>WHITNEY James Andrew</creatorcontrib><creatorcontrib>STEFANIDIS Dimitrios</creatorcontrib><creatorcontrib>XIN Yan</creatorcontrib><creatorcontrib>WANG Fang</creatorcontrib><creatorcontrib>BROWN Brandon H</creatorcontrib><creatorcontrib>HEMENWAY Jeffrey N</creatorcontrib><creatorcontrib>SHI Bing</creatorcontrib><creatorcontrib>REYNOLDS Troy</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>CARRA Ernest A</au><au>WARR Matthew Robert</au><au>MORRISON Henry</au><au>WHITNEY James Andrew</au><au>STEFANIDIS Dimitrios</au><au>XIN Yan</au><au>WANG Fang</au><au>BROWN Brandon H</au><au>HEMENWAY Jeffrey N</au><au>SHI Bing</au><au>REYNOLDS Troy</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS</title><date>2023-01-30</date><risdate>2023</risdate><abstract>The present invention relates to stable novel salt forms of N-(cyanomethyl)-4-(2-(4- morpholinophenylamino)pyrimidin-4-yl)benzamide that are suitable for the preparation of pharmaceutical formulations thereof, and their therapeutic use. La presente invención se refiere a formas novedosas estables de sales de N-(cianometil)-4-(2-(4-morfolinofenilamino)pirimidin-4-il )benzamida que son adecuadas para la preparación de las formulaciones farmacéuticas de las mismas y sus usos terapéuticos.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng ; spa
recordid cdi_epo_espacenet_MX2022015558A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title N-(CYANOMETHYL)-4-(2-(4-MORPHOLINOPHENYLAMINO)PYRIMIDIN-4-YL)BEN ZAMIDE HYDROCHLORIDE SALTS
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T05%3A44%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=CARRA%20Ernest%20A&rft.date=2023-01-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EMX2022015558A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true